Rinako Tanaka

Nagoya, 4668560, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Reward prediction is encoded by orexin neuron activity during motivated behavior.

Reward prediction is encoded by orexin neuron activity during motivated behavior.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 29, 2026

Phosphoproteomics identifies Rho-kinase-associated phospho-signaling and autophagy-associated alterations in the medial prefrontal cortex of a schizophrenia-related mouse model.

Phosphoproteomics identifies Rho-kinase-associated phospho-signaling and autophagy-associated alterations in the medial prefrontal cortex of a schizophrenia-related mouse model.

Journal: Pharmacological research

Published: December 19, 2025

Acute systemic immune challenge induces cognitive impairments and anhedonia through interferon-induced transmembrane protein 3 in adult male mice.

Acute systemic immune challenge induces cognitive impairments and anhedonia through interferon-induced transmembrane protein 3 in adult male mice.

Journal: Behavioural brain research

Published: July 31, 2025

Twinfilin-1 phosphorylation in reelin signaling regulates actin dynamics and spine development.

Twinfilin-1 phosphorylation in reelin signaling regulates actin dynamics and spine development.

Journal: Pharmacological research

Published: June 10, 2025

Distinct Effects of Nonselective Rho-Kinase Inhibitor Fasudil and Selective Rho-Kinase 2 Inhibitor KD025 on Serotonin and Dopamine Release in the Nucleus Accumbens of Mice.

Distinct Effects of Nonselective Rho-Kinase Inhibitor Fasudil and Selective Rho-Kinase 2 Inhibitor KD025 on Serotonin and Dopamine Release in the Nucleus Accumbens of Mice.

Journal: Neuropsychopharmacology reports

Published: June 05, 2025

Abnormal behaviors and glial responses in an animal model of tau pathology.

Abnormal behaviors and glial responses in an animal model of tau pathology.

Journal: Molecular brain

Published: March 11, 2025

Antipsychotic-like effects of the selective Rho-kinase 2 inhibitor KD025 in genetic and pharmacological mouse models of schizophrenia.

Antipsychotic-like effects of the selective Rho-kinase 2 inhibitor KD025 in genetic and pharmacological mouse models of schizophrenia.

Journal: Molecular psychiatry

Published: September 30, 2024

Genomic and Reverse Translational Analysis Discloses a Role for Small GTPase RhoA Signaling in the Pathogenesis of Schizophrenia: Rho-Kinase as a Novel Drug Target.

Genomic and Reverse Translational Analysis Discloses a Role for Small GTPase RhoA Signaling in the Pathogenesis of Schizophrenia: Rho-Kinase as a Novel Drug Target.

Journal: International journal of molecular sciences

Published: September 30, 2023

Inhibition of Rho-kinase ameliorates decreased spine density in the medial prefrontal cortex and methamphetamine-induced cognitive dysfunction in mice carrying schizophrenia-associated mutations of the Arhgap10 gene.

Inhibition of Rho-kinase ameliorates decreased spine density in the medial prefrontal cortex and methamphetamine-induced cognitive dysfunction in mice carrying schizophrenia-associated mutations of the Arhgap10 gene.

Journal: Pharmacological research

Published: October 26, 2022

Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia.

Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia.

Journal: European journal of pharmacology

Published: May 29, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026